(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|
Assets | |||
Total investments | --645.14M | 99.15%563.45M | --282.92M |
-Short term investments | --645.14M | 99.15%563.45M | --282.92M |
Cash and cash equivalents | --73.49M | 82.60%118.07M | --64.66M |
Restricted cash and cash equivalents | --11.91M | -89.38%1.7M | --15.99M |
Reinsurance recoverable | --282.67M | 85.50%256.12M | --138.07M |
Receivables | --47.76M | 35.40%39.92M | --29.49M |
-Accounts receivable | --47.62M | 31.64%38.82M | --29.49M |
-Taxes receivable | --136K | --1.11M | --0 |
Accrued investment income | --5.54M | 278.55%4.66M | --1.23M |
Deferred policy acquisition costs | --20.95M | 41.95%19.41M | --13.67M |
Net PPE | --7.65M | 25.64%7.6M | --6.05M |
Other assets | --3.81M | 46.79%2.7M | --1.84M |
Total assets | --1.11B | 81.86%1.03B | --565.21M |
Liabilities | |||
Policy holders liabilities reserve | --862.25M | 76.82%775.89M | --438.79M |
Payables | --35.92M | 60.62%40.48M | --25.2M |
-Accounts payable | --33.64M | 70.73%40.44M | --23.69M |
-Total tax payable | --2.28M | -97.23%42K | --1.52M |
Current accrued expenses | --6.69M | 23.88%14.9M | --12.03M |
Other liabilities | --8.45M | -22.34%4.51M | --5.81M |
Total liabilities | --913.31M | 73.46%835.78M | --481.83M |
Shareholders'equity | |||
Share capital | --240K | --0 | --0 |
-common stock | --240K | --0 | --0 |
Paid-in capital | --181.61M | 77.99%178.78M | --100.44M |
Retained earnings | --31.68M | 6,574.02%24.67M | ---381K |
Gains losses not affecting retained earnings | ---12.29M | 31.86%-11.37M | ---16.69M |
Total stockholders'equity | --201.24M | 130.38%192.08M | --83.37M |
Total equity | --201.24M | 130.38%192.08M | --83.37M |
Currency Unit | USD | USD | USD |
Audit Opinions | -- | Unqualified Opinion | -- |
No Data